miR-155 as a Biomarker in B-Cell MalignanciesHanne Due, Karen Dybkær, Martin Bøgsted et al.|BioMed Research International|2016Cited by 83
The application of human phase 0 microdosing trials: A systematic review and perspectivesPernille Svendsen, Hans Erik Johnsen, Tarec Christoffer El‐Galaly et al.|Leukemia & lymphoma/Leukemia and lymphoma|2015Cited by 10